Pasithea Therapeutics Corp. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Pasithea Therapeutics filed an 8-K on 2026-09-09 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). The filing contains no disclosed dollar amounts, counterparties, transaction details, or business developments. Only XBRL formatting files and exhibit metadata are present; substantive vote details are absent from the public disclosure.
Why this rating
Bare-bones procedural filing with no material facts disclosed. No transaction, financing, leadership change, or operational development evident. Routine SEC compliance filing.
Extracted items
- 5.07 shareholder vote
- 9.01 exhibits
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.